System Upgrade on Tue, May 28th, 2024 at 2am (EDT)
Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
Results: 1 - 2of2
Save this search
Please login to be able to save your searches and receive alerts for new content matching your search criteria.
EYE ON CHINA
Preview AbstractForum boosts Queensland-China research partnerships.
Taiwan researchers develop stress-releasing lactic fermented drink.
Salt cress genome yields new clues to salt tolerance.
Shanghai scientists may have found AIDS vaccine.
Improved production of Acetone–Butanol–Ethanol (ABE) by genome shuffling of Clostridium acetobutylicum CICC 8012.
BGI debuts new tool "PDXomics™" for tumor xenograft research and applications.
New study sheds light on the niche divergence between related ungulates at large scale.
MoU signed between PAS, CAS to enhance scientific cooperation.
RegeneRx and Lee's reach license agreement for TB4-based products.
BIOBOARD
Preview AbstractINDIA – Rice diplomacy in South Asia.
INDIA – Indian court's Novartis ruling keeps door to cheap drugs open.
INDONESIA – A blueprint for changing diabetes in Indonesia.
SINGAPORE – Understanding abnormal proteins in degenerative diseases.
SINGAPORE – Singapore scientist wins coveted Chen New Investigator Award 2013.
SINGAPORE – Singapore single-cell research center opens door for Asian biological discoveries.
THE PHILIPPINES – Wild parent spawns super salt-tolerant rice.
AUSTRALIA – Women: Hormone therapy won't harm your head.
AUSTRALIA – QLD government's removal of "green tape" will achieve results for all.
AUSTRALIA – Chinese herbs help cut diabetes symptoms.
AUSTRALIA – iSonea launches new Asthmasense™ cloud technology.
EUROPE – Bone Therapeutics and Erasme University Hospital start Phase IIa trial in osteoporosis.
NORTH AMERICA – Medicago and IDRI reports positive results for its Phase I clinical trial for an H5N1 vaccine.
NORTH AMERICA – Civitas Therapeutics announces positive Phase II clinical results an inhaled L-dopa for Parkinson's disease.
NORTH AMERICA – Impel NeuroPharma completes industry's first nose-to-brain human imaging study.
NORTH AMERICA – A new treatment option for alcohol dependence: Reduced consumption rather than abstinence.
NORTH AMERICA – Targacept completes recruitment in Phase IIb schizophrenia trial.
UNITED KINGDOM – ID deadly pathogens without growing bacteria.